Presentation

The AUGUSTUS Trial: Apixaban in Patients With Atrial Fibrillation and ACS/PCI - Design, Rationale, and Status

Presenter: Renato D. Lopes

November 01, 2017

REGISTER for free or LOG IN to view this content

The AUGUSTUS Trial: Apixaban in Patients With Atrial Fibrillation and ACS/PCI - Design, Rationale, and Status

Coronary

Presentation

TCT 2017

CAD Pharma

Up Next

Presentation

Debate: Does the Presence of Atrial Septal Aneurysm and/or a Large Degree of Shunting Identify Patients Most Likely to Benefit? Yes!

Presenter: Guillaume Turc

November 01, 2017

More slides +

Presentation

Implications of Absolute Vessel Size and Scaffold-Vessel Size Mismatch

Presenter: Patrick W. Serruys

November 01, 2017

Presentation

Managing AS Patients With Atrial Fibrillation in TAVR Patients Pharmacotherapy Considerations and LAAC Possibilities (WATCH-TAVR Trial)

Presenter: Samir R. Kapadia

November 01, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.